FDA investigates Scombrotoxin Fish Poisoning Linked to Yellowfin/Ahi Tuna

The FDA and state health authorities investigated scombrotoxin fish poisoning linked to yellowfin tuna (sometimes called ahi tuna). As a result of this investigation, FDA has placed Truong Phu Xanh Co, LTD of Vietnam, on Import Alert. The detained product will not enter the United States unless the importer proves that it meets U.S. food safety standards. FDA asked Truong Phu Xanh Co., LTD, to initiate a voluntary recall of all of its imported yellowfin tuna with production dates from January 2019 to the present. At this time, the firm has not recalled any product. The investigation has identified 47 illnesses of scombrotoxin fish poisoning that occurred between August 8, 2019, and October 15, 2019. Multiple samples have been collected and analyzed; with positive results for decomposition or high histamine levels in products imported from Truong Phu Xanh Co., LTD. While recalls were conducted at various points in the supply chain, additional products may still on the market that could cause illness. Truong Phu Xanh Co., LTD as identified as the common supplier of tuna that was likely consumed by most of the ill people. Because scombrotoxin fish poisoning causes temporary or medically reversible adverse health consequences this incident did not meet the threshold for the use of FDA’s mandatory recall authority. @ https://www.fda.gov/food/outbreaks-foodborne-illness/investigation-scombrotoxin-fish-poisoning-linked-yellowfinahi-tuna-fall-2019